Your browser doesn't support javascript.
loading
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients.
Åkerlund, Emma; Gudoityte, Greta; Moussaud-Lamodière, Elisabeth; Lind, Olina; Bwanika, Henri Colyn; Lehti, Kaisa; Salehi, Sahar; Carlson, Joseph; Wallin, Emelie; Fernebro, Josefin; Östling, Päivi; Kallioniemi, Olli; Joneborg, Ulrika; Seashore-Ludlow, Brinton.
Afiliação
  • Åkerlund E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Gudoityte G; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Moussaud-Lamodière E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Lind O; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Bwanika HC; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Lehti K; Department of Biomedical Laboratory Science, Norwegian University of Science and Technology NTNU, Trondheim, Norway.
  • Salehi S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Carlson J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Wallin E; Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Fernebro J; Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
  • Östling P; Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90089, USA.
  • Kallioniemi O; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Joneborg U; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.
  • Seashore-Ludlow B; Department of Pelvic Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
NPJ Precis Oncol ; 7(1): 111, 2023 Oct 31.
Article em En | MEDLINE | ID: mdl-37907613
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia